ClearPoint Neuro Inc vs Orion Office REIT Inc — how do they compare? ClearPoint Neuro Inc trades at $14.5 (market cap $454.21M), while Orion Office REIT Inc trades at $2.76 (market cap $158.01M). The key difference: ClearPoint Neuro Inc is far larger — about 2.9× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 2.89% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | ONL | |
|---|---|---|
Market Cap | $454.21M | $158.01M |
Sector | Health | Real Estate |
52-Week High | $29.60 | $3.04 |
52-Week Low | $8.66 | $1.93 |
Enterprise Value | $488.79M | $574.95M |
Dividend Yield | — | 2.89% |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $14.56, down slightly by 0.07% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth to $42 million but missed earnings estimates with a loss of $0.38 per share, reflecting ongoing investment in clinical and preclinical services. Despite negative net income margins and cash flow challenges, analyst consensus remains unanimously bullish with 3 buy ratings.
The outlook hinges on successful execution of growth initiatives in neuro drug delivery and regulatory progress with partners, though high valuation multiples and persistent losses pose significant risks. Near-term catalysts include Q3 2026 earnings and partner developments, but investors face volatility from operational cash burn and competitive pressures.
ONL trades at $2.80, up 1.82% with a bullish technical signal. The company reported mixed Q2 2026 results with an EPS beat but faces fundamental challenges including declining revenue and negative net income margins. Analyst consensus is split 50/50 between Buy and Hold ratings. Recent news highlights strategic review progress and portfolio repositioning efforts.
Outlook remains cautious due to persistent losses and revenue decline, though low P/B ratio and dividend payments offer some value. Key risks include continued negative profitability and high debt levels. The stock presents speculative value for investors tolerant of turnaround execution risk.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →